Diabetes mellitus is a major healthcare problem in India. Oral anti diabetic agents are the most commonly prescribed drugs for type 2 diabetes. The aim of the study was to evaluate the recent pattern of drug utilization of anti-diabetic drugs in diabetic patients and observe adverse drug events (ADEs) associated with anti-diabetic therapy. Methods: A prospective study was carried out in diabetic patients visiting the Diabetic OPD and those fulfilling inclusion criteria were included in study. Demographic data, drug utilization pattern and ADEs due to Anti-diabetic drugs were summarized. Results: In the present study, 110 (58.25%) were males and 96 (46.60%) were females. Majority of patients, Metformin was the most commonly prescribed drug. 71.1 % of patients were prescribed with triple therapy. Co-morbid condition was found in 91 patients where hypertension (18.44%) being the most common co-morbid condition. 81 ADRs were observed with GIT upset being the most common ADR reported. Conclusions: The present study helps to find out recent prescribing pattern of oral diabetic medications with different co-morbidities. Therefore, understanding of the existing prescribing patterns, trends of antidiabetic drugs their beneficial effect and mechanism can help to overcome progression of disease.
scite is a Brooklyn-based organization that helps researchers better discover and understand research articles through Smart Citations–citations that display the context of the citation and describe whether the article provides supporting or contrasting evidence. scite is used by students and researchers from around the world and is funded in part by the National Science Foundation and the National Institute on Drug Abuse of the National Institutes of Health.
customersupport@researchsolutions.com
10624 S. Eastern Ave., Ste. A-614
Henderson, NV 89052, USA
This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Copyright © 2025 scite LLC. All rights reserved.
Made with 💙 for researchers
Part of the Research Solutions Family.